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Breast cancer is the most frequently diagnosed cancer
affecting females in the world, including Taiwan, and is the
leading cause of cancer-related mortality in women.1
Because of the sheer magnitude of this disease, its psycho-
social impact and associated morbidity and mortality,
screening for early diagnosis may be one of the best strat-
egies we can employ to fight against this insidious ailment.
Although various radiographic modalities are readily avail-
able to help practitioners identify potentially troubling and
suspicious breast cancer lesions, mammography remains the
mainstay of breast cancer screening.2 Dr. Pan and colleagues
authored a very impressive article addressing the clinical
outcome of an 8-year nationwide mammography screening in
Taiwan.3 Based on the authors' findings, they concluded that
there is still room to ameliorate the efficacy of the breast
cancer screening process through comprehensive and con-
tinued education, improving the competence of cancer
detection, and decreasing the number of false negative cases
found in mammography screening in Taiwan.3 In addition,
Dr. Pan and his colleagues responded to Dr. Wang's com-
ment2 and wrote that the risk factors of breast cancer are
multifactorial; therefore, it is impractical to expect to reduce
the incidence rate of breast cancer from mammographic
screening alone.3 However, this response did not appear to
fully address the question. With the exception of certain
extremely rare neoplasms, the risk factors for the vast
majority of neoplasms are multifactorial.4,5 In addition, Pan
and colleagues further favored the value of mammographic
screening because a properly administered screening program
is used to detect lesions at an earlier stage, and hopefully
reduce subsequent medical expense and mortality.2 We
completely agree with Dr. Pan's response. However, in our
understanding, it would appear that the purpose of Dr. Wang
inquiry might be to question the benefit of mammographic
screening in Taiwan (did mammography screening indeed
increase the outcome of breast cancer?). With this question in
mind, a recently released report might be of some important
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presented the results of 25 years of follow-up in the Canadian
study.6 This study is important because it demonstrated the
following strengths, including its randomized design, an
intense level of ongoing intervention with five annual
mammography screenings, a high rate of compliance, and
comprehensive, long-term follow-up.7 The results of this
study showed that there was no difference in breast cancer
mortality between the mammography and control arms.
However, there was a significant excess of incidence of
invasive breast cancer observed in the mammography arm,
resulting in 22% overdiagnosis,7 suggesting that 22% of
screening-detected invasive breast cancers would not have
reduced a woman's life expectancy if left undetected.6 The
message might disappoint many physicians, including radi-
ologists and the majority of women who participate in reg-
ular mammography screening. This finding seemed to add
fuel to the recent firestorm surrounding this common
screening test,7 suggesting that the benefits of mammography
in routine practice may be questionable. In addition, this
message derived from Miller's study may be consistent with
our own knowledge; the results of Miller's study are strik-
ingly similardfor both lack of efficacy and extent of over-
diagnosisdto recent studies evaluating today's screening
programs.8 Due to the absence of any significant proven
benefits of mammography to combat breast cancer when such
screening was performed in all women, we argued against
such a practice.
Finally, Dr. Pan responded to Dr. Wang's other comment,
saying that a further analysis of the financial cost and emo-
tional support is beyond the scope of the original study they
made.2 We agree with Dr. Pan's answer. However, we hope that
in the future, such analysis will be performed because it brings
into question the entire mammography screening process as it
currently exists. If current screening methods are not
improved, and continue to fail to enhance the outcomes of
screened women, why should we do this? This controversy
relating to screening mammograms requires additional
research and discussion.References
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